Publications
5891 Results
- Journal / Conference
- Cancer 118(9):2420-2423;
- Year
- 2012
- Research Committee(s)
- Leukemia
- PMID
- PMID21928314
- PMC
- PMC3490403
- Study Number(s)
- S0106, S0112, SWOG-8600, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120), SWOG-9126, SWOG-9333, SWOG-9500, S9617, S9910, S9918
Impact of residual normal metaphases in core binding factor acute myeloid leukemia
- Journal / Conference
- United States and Canadian Academy of Pathology, abst. #1568; poster presentation;
- Year
- 2012
- Research Committee(s)
- Lymphoma
- Study Number(s)
- E2496
Tumor-associated macrophages predict inferior outcomes in locally advanced and advanced stage classical Hodgkins lymphoma - a correlative study from the E2496 intergroup trial http://www.abstracts2view.com/uscap12/view.php?nu=USCAP12L_1568
- Journal / Conference
- International Cognition and Cancer Taskforce, 2012 meeting, poster;
- Year
- 2012
- Research Committee(s)
- Breast
Patient reported cognitive impairments among women with breast cancer randomized to hormonal therapy alone versus chemotherapy followed by hormonal therapy: results from the TAILORx trial (PACCT-1)
- Journal / Conference
- Am J Respir Crit Care Med 185:2012:A6495; American Thoracic Society 2012 Intl Conf (May 18-23, 2012, San Francisco, CA), oral presentation;
- Year
- 2012
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000C
Effect of vitamin E and selenium on F2-isoprostanes, an oxidative stress biomarker, and lung function
- Journal / Conference
- Journal of Clinical Oncology (suppl 5; abstr 7); ASCO 2012 GU Sympos., oral presentation;
- Year
- 2012
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000
Vitamin E and the risk of prostate cancer: updated results of the Selenium and Vitamin E Prevention Trial (SELECT)
- Journal / Conference
- Journal of Urology 187, No. 4S, Supplement, e673, #1666; American Urological Association Annual Meeting, oral presentation;
- Year
- 2012
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S0353
SWOG S0353: Phase II trial of intravesical gemcitabine in patients with superficial bladder cancer with recurrence following 2 prior courses of BCG
- Journal / Conference
- American Society of Preventive Oncology Annual Meeting (March 3-6, Washington, DC); poster;
- Year
- 2012
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0000
Notifying study participants of increased prostate cancer risk due to vitamin E
- Journal / Conference
- Journal of Urology 187, No. 4S, Supplement, e492, #1217; American Urological Association Annual Meeting, oral presentation;
- Year
- 2012
- Research Committee(s)
- Cancer Control
- Study Number(s)
- SWOG-9217
The Prostate Cancer Prevention Trial (PCPT) risk calculator and the relationship between PSA and biopsy outcome
- Journal / Conference
- Cancer Causes and Control 23(9):1511-1518;
- Year
- 2012
- Research Committee(s)
- Cancer Control
- PMID
- PMID25359302
- PMC
- PMC4282945
- Study Number(s)
- SWOG-9217